Methods for inhibiting endometriosis
OA: closed
AI-generated summary
This patent describes a method for inhibiting endometriosis by administering an effective amount of a specific compound with defined chemical structural features to a human patient in need of treatment.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
A method of inhibiting endometriosis comprising administering to a human in need of treatment an effective amount of a compound having the formula Wherein R1 and R3 are independently hydrogen, -CH3, or wherein Ar is optionally substituted phenyl; R² is selected from the group consisting of pyrrolidine and piperidino; or a pharmaceutically acceptable salt of solvate thereof.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- europepmc
- last seen: 2026-08-05T06:13:34.187606+00:00